Navigation Links
Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M
Date:1/25/2012

Operating Income

$39.0

$28.9

35.0%

$180.6

$47.5

280.3%Net Income

$21.1

$28.4

(25.5%)

$132.2

$68.3

93.7%Earnings Per Share

$0.35

$0.45

(23.6%)

$2.16

$1.06

104.3%2011 Charges*

($31.1)

-($46.8)

-2010 Charges*

-

($18.4)-

($137.6)Favorable Income Tax items*

$1.8

$6.9$2.5

$17.3Operating Income, excluding items*

$57.9

$47.2

22.6%

$215.3

$185.1

16.3%  Operating Margin %, ex items*

10.9%

9.6%10.3%

9.6%Net Income, excluding items*

$44.6

$35.1

26.9%

$165.0

$138.6

19.1%Diluted EPS, excluding items*

$0.73

$0.56

30.4%

$2.70

$2.15

25.7%* See attached pro forma income statements for reconciliation of GAAP to pro forma amounts.

Operating Segment Results Early Development($ in millions)4Q114Q10ChangeFY 2011FY 2010ChangeNet Revenues

$234.5

$220.6

6.3%

$930.6

$840.3

10.7%GAAP Operating Income (Loss)

$17.7

$21.1

(16.3%)

$105.3

($32.0)

-GAAP Operating Margin %

7.5%

9.6%11.3%

(3.8%)2011 Charges

($15.0)

-($21.7)

-2010 Charges

-

($5.4)-

($124.6)2010 Cost Actions

-

--

($8.0)Pro Forma Operating Income

$32.6

$26.6

22.8%

$127.0

$100.7

26.1%Pro Forma OM%

13.9%

12.0%13.7%

12.0%The Early Development segment includes preclinical toxicology, analytical chemistry, clinical pharmacology, discovery support, and research products.  Net revenues in the fourth quarter of 2011 grew 6.3% year-on-year to $234.5 million, driven by the results from our new Alnwick, UK and Porcheville, France sites and clinical p
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Covance Decides to Pursue Its Original Preclinical Strategy in China
2. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
3. Covance Purchases Equity Stake in Caprion Proteomics
4. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
5. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
6. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
7. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
8. Covance Elects John McCartney to Companys Board of Directors
9. Covance to Present at the Drug Information Associations 45th Annual Meeting
10. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
11. Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
(Date:10/20/2014)... PLAINSBORO, N.J. (PRWEB) October 20, 2014 ... that the Sidney Kimmel Cancer Center at Thomas ... program. , Through the Strategic Alliance Partnership ... and OncLive will collaborate to raise awareness of ... cancer treatment, and other projects. Clinicians and other ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Local veterinary ... in an investigational study of donor stem cells for ... stem cell therapy and has performed clinical stem cell ... study is to determine if a single injection of ... joints can help reduce pain and inflammation in the ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The ... ABIM will take place at the Congress ... 2014 is now available at http://www.abim.ch ... and organizations from all over the globe ... the latest products and developments on the ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Aerolase, the manufacturer of,medical aesthetic lasers, announced today ... of Sanders Morris Harris Group (Nasdaq: SMHG ... to fund expansion into,new markets., The additional ... sales channel expansion into the market of about ...
... Sept. 19 /Xinhua-PRNewswire/ -- Latest agricultural news from,tootoo.com ... are welcoming the new,booming trends of Organic Farming ... ), Organic farming and organic foods have ... with domestic and overseas demands for organic,food, organic ...
... Mass., Sept. 19 PLC Systems Inc.,(Amex: PLC ... of failure to,meet listing qualifications dated September 17, 2008 ... Exchange. The notice,stated that the Company was not in ... the Company,s shareholders, equity was less,than $4,000,000 as of ...
Cached Biology Technology:Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion 2tootoo.com: China's Farmers Welcome the New Trend of Organic Farming 2PLC Systems Receives Delisting Notice From American Stock Exchange 2
(Date:10/18/2014)... sample of patients with undiagnosed, suspected genetic conditions, a ... a higher molecular diagnostic yield than traditional molecular diagnostic ... . The study is being released to coincide with ... Exome sequencing, which sequences the protein­coding region of the ... present in a cell or organism), has been rapidly ...
(Date:10/17/2014)... available in German . ... every day in order to reproduce? And why are there ... of the latest issue of the research journal Molecular ... biologist Steven Ramm from Bielefeld University Bielefeld has compiled this ... unusual for a female to copulate with several males in ...
(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
... Genetic variations in DNA repair patterns may increase risk ... it by as much as 77 percent, depending on the ... 15, 2009, issue of Clinical Cancer Research , a ... Pancreatic cancer is often identified in late stages, and thus ...
... 2008) New data released today by the Wildlife ... Parks (DWNP) reveals that a population of endangered Asian ... largest in Southeast Asia. WCS and DWNP researchers estimate ... Negara National Park a 4,343 square kilometer (1,676 ...
... crops, including corn, rapeseed and wheat, have been overestimated ... countries need to reset their expectations of agricultural biofuels ... a study led by Matt Johnston and Tracey Holloway ... Studies and Jon Foley of University of Minnesota, which ...
Cached Biology News:Jumbo-sized discovery made in Malaysia 2Nations that sow food crops for biofuels may reap less than previously thought 2Nations that sow food crops for biofuels may reap less than previously thought 3
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
Cytofix Buffer 100 mls...
Perm/Wash Buffer 250 Tests...
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Biology Products: